Royce & Associates LP boosted its holdings in Acadia Healthcare Company Inc (NASDAQ:ACHC) by 37.1% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 407,207 shares of the company’s stock after acquiring an additional 110,181 shares during the quarter. Royce & Associates LP owned 0.46% of Acadia Healthcare worth $14,334,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Alpine Woods Capital Investors LLC bought a new position in Acadia Healthcare in the 2nd quarter worth about $153,000. Bbva Compass Bancshares Inc. purchased a new position in shares of Acadia Healthcare in the 2nd quarter worth about $259,000. Strs Ohio purchased a new position in shares of Acadia Healthcare in the 3rd quarter worth about $308,000. BNP Paribas Arbitrage SA boosted its holdings in shares of Acadia Healthcare by 118.3% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 8,425 shares of the company’s stock worth $345,000 after purchasing an additional 4,566 shares in the last quarter. Finally, New Jersey Better Educational Savings Trust boosted its holdings in shares of Acadia Healthcare by 120.0% in the 3rd quarter. New Jersey Better Educational Savings Trust now owns 11,000 shares of the company’s stock worth $387,000 after purchasing an additional 6,000 shares in the last quarter.
A number of equities analysts have recently issued reports on ACHC shares. ValuEngine cut Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Friday, November 16th. BidaskClub cut Acadia Healthcare from a “buy” rating to a “hold” rating in a report on Thursday, September 13th. Cantor Fitzgerald reiterated a “hold” rating and issued a $39.00 price objective on shares of Acadia Healthcare in a report on Friday, November 16th. Zacks Investment Research upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Monday, November 12th. Finally, UBS Group started coverage on Acadia Healthcare in a report on Thursday, November 15th. They issued a “neutral” rating and a $39.00 price objective for the company. One research analyst has rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $42.27.
In related news, Director Reeve B. Waud sold 41,865 shares of the stock in a transaction dated Thursday, November 1st. The stock was sold at an average price of $45.00, for a total transaction of $1,883,925.00. Following the completion of the sale, the director now directly owns 14,213 shares in the company, valued at approximately $639,585. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 2.50% of the company’s stock.
Shares of ACHC stock opened at $33.10 on Wednesday. The stock has a market cap of $3.00 billion, a P/E ratio of 14.39, a P/E/G ratio of 1.47 and a beta of 0.16. Acadia Healthcare Company Inc has a 1-year low of $28.02 and a 1-year high of $45.35. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.26 and a quick ratio of 1.26.
Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Monday, November 5th. The company reported $0.55 earnings per share for the quarter, missing the consensus estimate of $0.64 by ($0.09). The company had revenue of $760.90 million for the quarter, compared to analysts’ expectations of $760.46 million. Acadia Healthcare had a net margin of 7.43% and a return on equity of 7.71%. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.58 earnings per share. As a group, equities research analysts expect that Acadia Healthcare Company Inc will post 2.3 EPS for the current fiscal year.
WARNING: This report was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another domain, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/12/05/acadia-healthcare-company-inc-achc-shares-bought-by-royce-associates-lp.html.
Acadia Healthcare Profile
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.
Recommended Story: What is insider trading?
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company Inc (NASDAQ:ACHC).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.